Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve Inc. is a Canadian healthcare technology company. The Company and its subsidiaries, Medivolve Pharmacy Inc. (doing business as Marbella Pharmacy) and Kedy Ying Jao D.O., a Medical Corporation, operate a distributed network of two retail patient-care locations in California, United States. It has two business units: Medivolve Pharmacy Division (MPD) and Medivolve Clinic Services Division (MCSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine and psychiatry to patients in Southern California. MCSD provides licensed healthcare through a clinic in Brea, California, United States. MCSD is focused on developing a telehealth platform, which connects patients with physicians, and facilitates and manages the provision of virtual consultation, diagnosis, and treatment services in partnership with qualified health practitioners.


OTCPK:MEDVF - Post by User

Post by Sarb99on Aug 04, 2020 9:02am
159 Views
Post# 31360022

Anonymous will not be successful now we get real news "sales

Anonymous will not be successful now we get real news "salesThey are just digging deeper hole for themselves as now it is different story compare to April and while QuestCap waiting for EUA approval.

  1. Questcap now have FDA (EUA approved partner) No more waiting for approval. So, they can actually sell Covid-19 test kits.
  2. Spectral Analytics Announces Positive Results IN VITRO Research for the Upcoming Patient Trial for COVID-19 Treatment. (Done the groundwork https://www.wfmj.com/story/42414020/spectral-analytics-announces-positive-results-in-vitro-research-for-the-upcoming-patient-trial-for-covid-19-treatment so less time needed.
  3. Sunnybrook Research team has isolated the COVID-19 virus and working on next phase.
  4. Sinai Health already moving In the coming months, the team hopes to test up to 1,000 volunteers as part of the next phase of their research into a mass-scale serology test for COVID-19. https://www.utoronto.ca/news/u-t-antibody-test-detects-past-infection-quality-immune-response-covid-19
  5. QuestCap own 40% stake in Amino Therapeutics, Inc and they are also looking cure for Covid-19. At AMINO, we aim to tackle challenges before they turn into threats. Our team consists of researchers trained at Harvard, MIT and Mayo Clinic, all working in tandem with intelligent machinery and exclusively licensed gene-editing technologies. Supported by a vertically integrated backbone, our company is equipped with unique advantages that allow it to preserve time and capital at every stage from lab to testing. https://www.aminothera.com/

<< Previous
Bullboard Posts
Next >>